Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG

Journal of Clinical Virology - Tập 128 - Trang 104394 - 2020
Alexander Krüttgen1, Christian G. Cornelissen2, Michael Dreher2, Mathias Hornef3, Matthias Imöhl1, Michael Kleines1
1Laboratory Diagnostic Center, University Hospital RWTH Aachen, Germany
2Department of Pneumology and Intensive Care Medicine, University Hospital RWTH, Aachen, Germany
3Department of Medical Microbiology, University Hospital, RWTH Aachen, Germany

Tài liệu tham khảo

Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 Okba, 2020, Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease 2019 patients, Emerg. Infect. Dis., 26 de Ory, 2018, Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG, J. Clin. Lab. Anal., 32 Haveri, 2020, Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020, Euro Surv.: Bulletin Europeen Sur Les Maladies Transmissibles = Eur. Commun. Dis. Bull., 25